K134035

Substantially Equivalent

TRANSONIC HCM 103 SYSTEM

Applicant: Transonic Systems, Inc.
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2013-12-31
Decision date: 2014-09-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ithaca, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.